Raltegravir Tablets are bioequivalent to Isentress ... On May 7, the global pharma major launched Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600 mg, and 800 mg, following the approval ...

During the first 48 weeks of the study, patients were randomised to one of four dose regimens (100, 200, 400 and 600 mg twice daily). After 48 weeks, all groups receiving raltegravir received 400 ...

New Delhi: Drug majors Cipla and MSD announced an India specific strategic partnership under which the former will have a non-exclusive license to market, promote and distribute MSD's 'raltegravir' ...

fHIV-NAT, Thai Red Cross AIDS Research Center and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand ...

Your doctor will discuss the risks and benefits of using ISENTRESS 400 mg twice daily if you are pregnant. There are limited data on the use of ISENTRESS HD 1200 mg (2 x 600 mg) once daily in ...

The 400 mg tablet should not be substituted for the new 600 mg tablet to create a 1200 mg once-daily dose. Raltegravir once-daily recently received notice of compliance from Health Canada. "For the ...

Presently, Isentress is approved in a 400 mg twice daily formulation for the treatment of HIV-1 infection in adults. We remind investors that the once-daily formulation of Isentress (600 mg ...